Tedeschi G, Griffiths A N, Smith A T, Richens A
Br J Clin Pharmacol. 1985 Oct;20(4):361-7. doi: 10.1111/j.1365-2125.1985.tb05078.x.
The effects of six nightly doses of temazepam (20 mg), nitrazepam (10 mg) and placebo on saccadic eye movements, critical flicker fusion, choice reaction time and on subjective feelings were studied in a double blind cross-over study in eight volunteers. Testing was performed on nights 1 and 6 of treatment. Nitrazepam, a benzodiazepine with a long elimination half-life produced a residual performance impairment on night 1 that had disappeared by night 6, despite higher serum concentrations of the drug on the sixth night of treatment. Temazepam, with a shorter elimination half-life produced no significant performance impairment on night 1, but by night 6 a significant impairment of saccadic eye movements (P less than 0.05), was seen 1 h after drug intake. We conclude that tolerance developed to the sedative action of nitrazepam over the 6 night period of the study. No evidence of tolerance was seen with temazepam.
在一项双盲交叉研究中,对8名志愿者每晚服用6次替马西泮(20毫克)、硝西泮(10毫克)和安慰剂后对眼球跳动、临界闪烁融合、选择反应时间及主观感受的影响进行了研究。测试在治疗的第1晚和第6晚进行。硝西泮是一种消除半衰期长的苯二氮䓬类药物,在第1晚产生了残余的行为能力损害,到第6晚时这种损害已消失,尽管在治疗的第6晚药物的血清浓度更高。替马西泮消除半衰期较短,在第1晚未产生明显的行为能力损害,但到第6晚,在服药1小时后出现了明显的眼球跳动损害(P<0.05)。我们得出结论,在该研究的6晚期间,对硝西泮的镇静作用产生了耐受性。未观察到替马西泮产生耐受性的证据。